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Plasmin is not protective in experimental renal interstitial
fibrosis.
Background. The plasminogen-plasmin system has potential
beneficial or deleterious effects in the context of renal fibrosis.
Recent studies have implicated plasminogen activators or their
inhibitors in this process.
Methods. The development of renal interstitial fibrosis was
studied in mice genetically deficient in plasminogen (plg−/−
mice) and littermate controls (plg+/+ mice) by inducing uni-
lateral ureteric obstruction (UUO) by ligating the left ureter.
Results. Collagen accumulation in the kidney was decreased
in plg−/− mice at 21 days compared with plg+/+ mice by hy-
droxyproline assay (plg+/+ 19.0 ± 1.2 lg collagen/mg tissue,
plg−/− 15.6 ± 0.5 lg collagen/mg tissue, P = 0.04). Macrophage
accumulation in plg−/− mice was reduced at 21 days, consis-
tent with a role for plasmin in macrophage recruitment in this
model. Myofibroblast accumulation, assessed by the expres-
sion of a-smooth muscle actin (a-SMA), was similar in both
groups at both time points. Endogenous plasmin played a role
in the activation of transforming growth factor-b (TGF-b), as
plg−/− mice had lower ratios of big-h3:TGF-b1 mRNA than
plg+/+ mice. Matrix metalloproteinase (MMP)-9 activity was
unchanged in the absence of plasmin, but MMP-2 activity was
decreased.
Conclusion. Plasminogen, the key proenzyme in the
plasminogen-plasmin system, does not protect mice from ex-
perimental interstitial fibrosis and may have significant patho-
genetic effects. These findings, together with other recently
published studies in the biology of renal fibrosis, imply that ef-
fects of proteins such as plasminogen activator inhibitor-1 (PAI-
1), tissue-type plasminogen activator (tPA), and urokinase-type
plasminogen activator receptor (uPAR) on renal fibrosis occur
independently from the generation of plasmin.
Interstitial fibrosis is an important common pathway to
end state renal disease. The infiltration of macrophages,
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the presence of interstitial cells expressing a-smooth mus-
cle actin (a-SMA) and laying down of interstitial matrix
proteins including collagen are prominent features of this
process [1]. A number of factors, including inflammatory
cells, the activity of tubular cells, the accumulation of my-
ofibroblasts, the secretion of soluble factors and net bal-
ance between deposition and turnover of matrix proteins
are thought to influence the rate of progression of fibrosis.
The plasminogen-plasmin system performs important
intravascular roles via the conversion of fibrin to fibrin
degradation products by plasmin. Plasmin is generated
by conversion of its proenzyme, plasminogen to plas-
min by either tissue-type plasminogen activator (tPA) or
urokinase-type plasminogen activator (uPA). Plasmino-
gen is the only known substrate for plasmin and mice defi-
cient in plasminogen are totally plasmin deficient [2]. The
similar phenotype and absence of plasmin activity of mice
deficient in either plasminogen, or both tPA and uPA has
demonstrated that tPA and uPA are the only physiolog-
ically relevant activators of plasminogen in vivo [2, 3].
tPA is the major glomerular plasminogen activator, while
uPA is more prominently expressed in the renal tubuloin-
terstitium [4, 5]. In addition to direct effects on soluble
plasminogen, uPA can act via a cell-associated receptor,
the uPA receptor (uPAR). Both tPA and uPA are inhib-
ited by plasminogen activator inhibitors (PAIs), the best
known being PAI-1. Studies in fibrin-related/dependent
glomerular disease have shown that endogenous plas-
min limits glomerular fibrin accumulation [6]. However,
the role of the plasminogen-plasmin system in renal fi-
brosis is less clear. Plasmin activity is increased approxi-
mately threefold in hydronephrotic mouse kidneys, with
the increase being apparent by day 3 [7]. Studies using
the same model as the current studies showed that de-
spite similar renal plasmin activity mice deficient in PAI-
1 or tPA showed protection from disease [7, 8], while
uPAR-deficient mice demonstrated accelerated fibrosis
[9]. These results suggest roles for PAI-1, tPA, and uPAR
that might be independent from their actions to inhibit or
facilitate the conversion of plasminogen to plasmin. How-
ever, experimental fibrosis in other organs, including the
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lungs and liver [10, 11], is accelerated in the absence of
plasminogen.
Plasmin, by virtue of its ability to directly degrade
matrix and activate matrix metalloproteinases (MMPs),
could have a protective role in limiting collagen and ma-
trix accumulation in renal fibrosis. However, plasmin has
the capacity to play pathogenetic roles in renal disease via
its potential role in leukocyte recruitment [12] or by con-
verting transforming growth factor-b (TGF-b), a growth
factor that plays a pathogenic role in renal fibrosis [13–
15] to its active form. Plasmin may directly activate latent
TGF-b or release latent TGF-b from storage sites within
matrix [16]. Plasmin also has the potential to activate
MMPs that could participate in tubular basement mem-
brane degradation [8]. The availability of plasminogen-
deficient mice (plg−/− mice) [2] that are totally deficient
in plasmin but have normal levels of tPA, uPA, and PAI-1
[17] allows examination of the role of endogenous plas-
min in fibrotic renal injury. These studies address the hy-
pothesis that in experimental renal interstitial fibrosis,
endogenous plasmin is protective. They use mice that are
plasminogen deficient (plg−/− mice) and littermate con-
trols (plg+/+) in which experimental unilateral ureteric
obstruction (UUO) or ligation has been induced. Fibrotic
renal disease in the obstructed kidney was studied at an
early time point (7 days after ureteric ligation) and a later
time point (21 days after ligation).
METHODS
Experimental design
Mice with a genetic deletion of plasminogen (plg−/−)
[2] on a C57BL/6 × 129/SvJ background, backcrossed
once onto a C57BL/6 background (75% C57BL/6 and
25% 129/SvJ) were bred in an SPF facility (Leuven, Bel-
gium) by intercrossing plg+/− males and females. Off-
spring were genotyped and plg−/− mice, all carrying
two copies of the disrupted allele and littermate control
plg+/+ mice were identified. Mice aged 8 to 12 weeks
were used for experiments. All mice in experiments at
7 days were male; mice studied at 21 days were female.
The left ureter of each mouse was ligated under general
anesthesia. Renal injury was studied at 7 days and at 21
days after UUO. Histologic assessment was performed
on coded slides. Results are expressed as the mean ±
SEM. The significance of differences between groups was
determined by Mann-Whitney U test (GraphPad Prism,
GraphPad Software Inc., San Diego, CA, USA). The fol-
lowing two groups of mice were studied: (1) plg+/+ mice,
UUO day 7 (N = 8), UUO day 21 (N = 9); and (2) plg−/−
mice, UUO day 7 (N = 7), UUO day 21 (N = 8).
Assessment of interstitial fibrosis and
collagen accumulation
Kidney tissue was fixed in 2% paraformaldehyde, em-
bedded in paraffin, and 3 lm tissue sections from all mice
were stained with picro-Sirius red (Sigma Chemical Co.,
St. Louis, MO, USA) identifying collagen fibers (in red)
[18]. Different sections from the same mice were also
stained with Masson trichrome identifying collagen fibers
(in blue). Histologic assessment of collagen deposition
was determined by the point counting method using a
10 × 10 grid. A minimum of 10 high power (×400) fields
were assessed per animal and results expressed as % to-
tal interstital cortical area, excluding glomeruli, blood
vessels, and periglomerular and perivascular areas [19].
Biochemical measurement of renal collagen content was
assessed by determining total hydroxyproline according
to the method of Bergman and Loxley [20]. An accu-
rately weighed portion of renal tissue (one fourth of the
obstructed or contralateral kidney) was hydrolysed in 6 N
HCl by incubation at 110◦C overnight. The hydrolysate
was neutralized with 2.5 mol/L NaOH. Hydrolysates in
isopropanol were oxidised by chloramine T then mixed
with p-dimethylaminonbenzaldehyde (25 minutes, 60◦C)
and the absorbance measured at 558 nm. Total collagen
was calculated using the assumption that collagen con-
tains 12.7% hydroxyproline by weight. Results were ex-
pressed as lg/mg kidney wet weight.
Interstitial macrophage accumulation
Kidney tissue was fixed in periodate lysine para-
formaldehyde (PLP) for 4 hours, washed in 7% sucrose
solution, then frozen in liquid nitrogen. Tissue sections
(6 lm) were stained to demonstrate macrophage infil-
trate with F4/80 using a three-layer immunoperoxidase
technique, as previously described [21, 22]. As individ-
ual macrophages could not be reliably counted, a min-
imum of 10 high power fields were assessed per animal
and cortical interstitial infiltrate scored using a scale of 0
to 3+ [0, normal (equivalent to normal animals and the
contralateral kidney of experimental animals); 1, 10%
to 40% interstitium; 2, 40% to 70% interstitium; and 3,
>70% interstitium].
Renal myofibroblast accumulation
Interstitial myofibroblasts were assessed by detecting
a-SMA by immunohistochemistry and Western blotting.
For immunohistochemistry, paraformaldehyde-fixed
tissue sections (3 lm) were stained with peroxidase-
conjugated murine antihuman a-SMA 1A4 monoclonal
antibody using the enhanced polymer one-step staining
(EPOS) reagent (Dako Corp., Carpinteria, CA, USA).
Briefly, a-SMA antibody was incubated overnight
at 4◦C and antibody binding detected using 3,3′-
diaminobenzidine (DAB) as the chromogen (Sigma
Chemical Co.) and counterstained with nuclear fast
red (BDH Chemicals, Poole, England). Dako EPOS
immunoglobulins-horseradish peroxidase (HRP)–
specific negative control was used to control for any
nonspecific staining. Interstitial a-SMA accumulation
was assessed by the point counting method (as above).
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For Western blotting, kidney samples (four mice per
group at each time point) were homogenized in protein
extraction buffer (0.01 mol/L CaCl2 and 0.25% Triton
X-100). The samples were centrifuged at 13000g, 4◦C
for 30 minutes. Supernatant collected and protein
concentrations were determined using the Bradford
protein assay. Protein samples (10 lg) were separated
by 10% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) under reducing conditions and
transferred to a nitrocellulose membrane. Membranes
were stained with mouse anti-a-SMA antibody (1:1000,
1A4) (Dako) or mouse-anti-b-tubulin antibody (1:1000,
D-10) (Pierce, Rockford, IL, USA) and followed by goat
anti-mouse IgG conjugated to HRP (1:10000, Pierce).
Detection was performed using SuperSignal West Pico
Chemiluminescent substrate according to the manufac-
turer’s recommendations (Pierce). a-SMA expression
was analyzed using Image Gauge (Science Lab, Fuji
Photo Film, Tokyo, Japan) and results expressed as the
ratio to b-tubulin.
Assessment of intrarenal TGF-b1 and TGF-b-inducible
gene-h3 (big-h3) mRNA in obstructed kidneys
To assess the potential for plasmin to activate TGF−b ,
TGF-b1, and big-h3 (a TGF-b–induced gene product
[23]) mRNA were assessed in obstructed kidneys from
plg+/+ (UUO day 7, N = 4; UUO day 21, N = 4) and
plg−/− mice (UUO day 7, N = 3; UUO day 21, N =
4) with UUO. Frozen mouse kidney tissue, stored at
−80◦C was homogenized, total RNA was isolated using
TRIzol reagent (Life Technologies, Grand Island, NY,
USA), and purified RNA was dissolved in sterile water
and quantified spectrophotometrically. RNA quality was
verified on a 1% denaturing agarose gel by visualizing
the 18S and 28S RNA bands. Four micrograms of total
RNA was treated with RQ1 DNase (1 U/lL) (Promega,
Madison, WI, USA) to remove genomic DNA. The
DNase treated RNA was reverse transcribed with 1 lL
(2 lg/lL) random hexamers (Roche Diagnostics,
Mannheim, Germany) and incubated for 5 minutes at
70◦C. After cooling on ice for 5 minutes, 5 lL of 5× avian
myeloblastosis virus (AMV) reaction buffer, 2.5 lL of
10 mmol/L deoxynucleoside triphosphate (dNTP) mix,
0.5 lL RNase inhibitor (40 U/lL) (Roche Diagnostics),
0.5 lL AMV reverse transcriptase (25 U/lL) (Roche Di-
agnostics) and 4.5 lL of diethyl pyrocarbonate (DEPC)
water was added. The reaction mixture was incubated at
37◦C for 60 minutes to complete cDNA synthesis, then
cDNA samples were stored at −20◦C for future use.
TGF-b1 and big-h3 gene expression were measured
and quantified using ABI Prism 7000 Sequence Detec-
tion System (Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s instructions. Sequence
specific primers were designed to span exon-exon bound-
aries to avoid amplification of contaminating genomic
Table 1. Sequences for analysis of mRNA for transforming growth
factor-b1 (TGF-b1) and big-h3 by real-time quantitative reverse
transcription-polymerase chain reaction (RT-PCR)
Sequence
TGF-b1
Forward primer AGAAGTCACCCGCGTGCTA
Reverse primer TGTGTGATGTCTTTGGTTTTGTCA
Probe TGGTGGACCGCAACAACGCAAT
big-h3
Forward primer TCCTTGCCTGCGGAAGTG
Reverse primer GGAGAGCATTGAGCAGTTCGA
Probe TGGACTCCCTGGTGAGCAACGTCAAC
DNA using the Primer Express software, version 1.5
(Applied Biosystems) (Table 1). Primers were obtained
from Sigma-Aldrich and fluorescent probes from Applied
Biosystems.
For the relative quantification of the target gene
and the endogenous control 18S ribosomal RNA (18S),
real-time quantitative reverse transcription-polymerase
chain reaction (RT-PCR) was performed using the Taq-
Man assay which utilizes the 5′ nuclease activity of
DNA polymerase to hydrolyze a fluorescence probe
bound to its target amplicon. A TaqMan probe con-
tains a fluorescence reporter dye [6-carboxyfluorescein
(FAM)] at the 5′-end and a fluorescent quencher [6-
carboxytetramethylrhodamine (TAMRA)] at the 3′-end.
A commercial, predeveloped (18S) control kit labeled
with the fluorescent reporter dye (VIC) on the 5′ end, and
the quencher (TAMRA) on the 3′ end (Applied Biosys-
tems) was used as the endogenous control.
Amplification efficiencies of the target genes, and
the endogenous control, 18S were approximately equal
as demonstrated by validation experiments (data not
shown) allowing relative quantitation to be performed
between the target gene and endogenous control. Primer
and probe concentrations were optimized before exper-
iments were completed. The 25 lL PCR mixture con-
tains 12.5 lL of TaqMan Univeral PCR Master Mix,
500 nmol/L primers (forward and reverse), 100 nmol/L
of TaqMan probe, and 1 lL of cDNA template. PCR
was performed at 50◦C for 2 minutes, 95◦C for 10 min-
utes to activate the AmpliTaq Gold polymerase (Ap-
plied Biosystems), then run for 40 cycles at 95◦C for
15 seconds and 60◦C for 1 minute. Experiments were
performed in triplicate for each sample and no template
controls were added to ensure that amplification was not
due to contamination of other components within the
PCR mixture. Data analysis was performed using the Ap-
plied Biosystems Comparative CT method (http://www.
appliedbiosystems.com.au/sdscompendiums.htm).
MMP-2 and MMP-9 activation in the absence
of plasminogen
Gelatin zymography was performed to analyze acti-
vated MMP-2 and MMP-9 as previously described [24]
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Fig. 1. Renal histopathology in plg+/+
and plg−/− mice. Interstitial renal fibro-
sis developed in both plasminogen-intact
and plasminogen-deficient mice. Disease was
moderate at day 7 in both plg+/+ mice (A)
and plg−/− mice (B), and severe at day 21,
again in both plg+/+ mice (C) and plg−/−
mice (D) (high power, ×400, Sirius red stain,
collagen appearing red).
using four mice from each time point. Samples (10 lg pro-
tein/well) were loaded onto 10% SDS-polyacrylamide
gels containing 1 mg/mL gelatin as substrate (Bio-Rad
Laboratories, Hercules, CA, USA). Human MMP-2 and
MMP-9 (a gift from Dr L.A. Salamonsen, Melbourne,
Australia) were used as standards. After protein sepa-
ration by electrophoresis under nonreducing conditions,
the gel was washed in 0.05 mol/L Tris buffer pH 7.4 (con-
taining 5 mmol/L CaCl2, 1 lmol/L ZnCl2, 0.01% NaN3,
and 0.25% Triton X-100) for 30 minutes at room temper-
ature then in Tris buffer without Triton X-100 for 15 min-
utes at room temperature before incubating at 37◦C for
48 hours. The gel was stained with Coomassie blue (Bio-
Rad Laboratories) and pro-MMPs and active MMPs
were visualized by negative staining at the appropriate
molecular weights. Each lytic band was analyzed using
Image Gauge and results expressed as arbitrary units
(AU).
RESULTS
Endogenous plasminogen and plasmin does
not protect mice from renal interstitial fibrosis
or collagen accumulation
Obstructed kidneys from genetically normal plg+/+
mice developed progressive renal cortical thinning and
fibrosis from day 7 to day 21 of disease, compared with
contralateral kidneys (obstructed kidneys day 7, Fig. 1A)
(obstructed kidneys day 21, Fig. 1C). However, renal
interstitial fibrosis was not accelerated in the absence
of plasmin (day 7, Fig. 1B; day 21, Fig. 1D). Histo-
logic assessment by point counting of Sirius red–stained
sections and Masson trichrome–stained sections to de-
rive the percentage of cortical interstitial section stain-
Table 2. Histologic assessment of collagen accumulation using both
Sirius red staining and Masson trichrome staining, by point counting
(10 × 10 grid) of a minimum of 10 high power fields per animal,
expressed as % total interstitial cortical area, excluding glomeruli,
blood vessels, and periglomerular and perivascular areas
Sirius red Masson trichrome
Day 7
Obstructed plg+/+ 14.0 ± 2.7 11.0 ± 2.9
plg−/− 8.9 ± 1.3 27.4 ± 7.6
Day 21
Obstructed plg+/+ 78.5 ± 4.7 65.5 ± 5.6
plg−/− 82.3 ± 3.2 55.8 ± 5.6
P values for plg+/+ vs. plg−/− mice at day 7 were P = 0.12 for Sirius red
staining and P = 0.13 for Masson trichrome staining (Mann-Whitney U test).
ing for collagen showed a similar degree of progressive
renal fibrosis in obstructed kidneys from both plg+/+
and plg−/− mice (Table 2). Quantitation of renal col-
lagen accumulation (Fig. 2) by hydroxyproline assay
showed similar degrees of collagen content in the con-
tralateral (unobstructed) and normal kidneys (4.6 ± 0.2
lg collagen/mg kidney). In obstructed kidneys, there
was no difference between plg+/+ and plg−/− mice at
7 days (plg+/+ 7.6 ± 0.4 lg collagen/mg kidney and
plg−/− 7.6 ± 0.3 lg collagen/mg kidney) (Fig. 2A). At
21 days, not only did endogenous plasmin not provide
any protection from the development of renal fibrosis,
renal collagen accumulation was significantly less in mice
genetically deficient in plasminogen, and therefore plas-
min [plg+/+ 19.0 ± 1.2 lg collagen/mg kidney and plg−/−
15.6 ± 0.5 lg collagen/mg kidney (P = 0.04)] (Fig. 2B).
Macrophage recruitment is diminished in the absence
of plasminogen
Plasmin has the capacity to promote macrophage re-
cruitment into inflamed tissues [12]. Immunostaining
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Fig. 2. Accumulation of collagen in normal contralateral and ob-
structed kidneys from plg+/+ and plg−/− mice. Hydroxyproline assay
demonstrates no difference at 7 days (A) and a small but significant re-
duction in collagen accumulation at day 21 (B) ∗P = 0.04. The dotted
lines represent values for unobstructed normal mice on which opera-
tions have had not been performed.
using the macrophage specific monoclonal antibody
F4/80 showed that macrophages were present in both
plg+/+ and plg−/− mice at 1 week (Fig. 3A, B, and E)
but the macrophage infiltrate was diminished in the in-
terstitium of plg−/− mice (Fig. 3D and E) compared with
plg+/+ mice at 3 weeks (Fig. 3C and E).
Interstitial myofibroblast accumulation is not affected
by plasminogen deficiency
Tubular cells undergo transdifferentiation into myofi-
broblasts under inflammatory stimuli and participate in
fibrosis. Myofibroblasts can be identified by their expres-
sion of a-SMA. Therefore a-SMA was used as a surrogate
marker for myofibroblast accumulation and assessed by
Western blotting and point counting of immunohistologic
sections. Assessed by point counting of a-SMA–positive
areas in the cortical interstitium, there was no difference
in the accumulation of myofibroblasts between plg+/+
mice and plg−/− mice (day 7, plg +/+ 41.0% ± 3.4%
of the sections involved and plg−/− 48.1% ± 7.5%; day
21, plg+/+ 43.9% ± 2.8% and plg−/− 40.5% ± 3.0%).
Similarly, semiquantitative assessment a-SMA protein by
Western blotting revealed no differences between plg+/+
and plg−/− mice [day 7, plg+/+ 0.26 ± 0.09 (a-SMA:b-
tubulin ratio) and plg−/− 0.42 ± 0.09 (P = 0.63); day 21,
plg+/+ 0.63 ± 0.07 and plg−/− 0.59 ± 0.20 (P = 0.49)].
The big-h3 to TGF-b1 mRNA ratio is diminished
in plasminogen-deficient mice with UUO
To assess whether plasmin is likely be involved in the
activation of TGF-b in vivo, mRNA for TGF-b1 and big-
h3 (a TGF-b responsive gene [23]) were measured in ob-
structed kidneys from plg+/+ and plg−/− mice (Fig. 4).
There was a good correlation between levels of mRNA
for TGF-b1 and big-h3 in both plg+/+ mice (r2 = 0.76)
and plg−/− mice (r2 = 0.84). The ratio of big-h3:TGF-b1
was lower in plg−/− mice at both time points, with the
difference approaching statistical significance (P = 0.057
for both day 7 and day 21).
MMP-2 and MMP-9 in fibrotic kidneys from plg+/+
and plg−/− mice
MMPs have the capacity to be activated by plasmin and
may play a role in matrix degradation. Gelatin zymogra-
phy was performed on kidneys from plg+/+ and plg−/−
mice at both 1 and 3 weeks. Active and pro-MMP-9
were unchanged in the absence of plasminogen (Table 3)
(Fig. 5). Active MMP-2 levels in contralateral kidneys
from either strain were too low to be reliably detected
(Table 4) (Fig. 5). Levels rose to a similar degree in both
plg+/+ and plg−/− mice at week 1, but were lower in the
absence of plasminogen at 3 weeks [plg+/+ 46.2 ± 1.4 AU
and plg−/− 25.1 ± 2.1 AU (P = 0.03)]. This reduction in
active MMP-2 in obstructed kidneys in the absence of
plasminogen was not a result of reduced total MMP-2, as
analysis of pro-MMP-2 and active MMP-2 levels showed
no reduction in total MMP-2 in plg−/− mice [plg+/+
93.8 ± 4.2 AU and plg−/− 83.1 ± 7.7 AU (P = 0.34)].
DISCUSSION
These studies demonstrate for the first time that plas-
min is not protective in renal interstitial fibrosis, and
provide some evidence that plasmin may in fact be patho-
genetic. As plasmin promotes matrix remodelling, it has
been assumed that endogenous plasmin would play a
protective role in renal interstitial fibrosis, by limiting
collagen and other matrix accumulation. However, this
hypothesis (that plasmin would be protective in renal fi-
brosis) has not been tested. Plasmin activity is increased
threefold in murine UUO [7], while recent studies in mice
deficient in some of the other proteins that play a role in
the plasminogen-plasmin system, namely PAI-1 [7], tPA
[8], and uPAR [9], have shown pathogenetic roles (in the
case of tPA perhaps somewhat unexpectedly) for PAI-1
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Fig. 3. Macrophage infiltrate in obstructed
kidneys from plg+/+ and plg−/− mice. Pho-
tomicrographs of interstitial macrophages.
At 7 days there was a moderately dense
macrophage infiltrate in both plg+/+ (A)
and plg−/− (B). At 21 days, the infiltrate
in plg+/+ mice (C) was more dense than
in plg−/− mice (D) (medium power, ×200,
F4/80+ cells, black reaction product, nuclear
fast red counterstain). (E) Semiquantitative
analysis of macrophage infiltration, showing
reduced infiltration at 21 days in mice defi-
cient in plasminogen.
and tPA, and a protective role for uPAR in the patho-
genesis of renal fibrosis. These changes seemed to have
occurred independent of plasmin generation, in the case
of PAI-1 potentially by direct effects on macrophages
and myofibroblasts [7], with tPA by promoting basement
membrane degradation and enhancing tubular epithelial
to myofibroblast transformation [8], while the protective
effects of uPAR are possibly due to enhanced degrada-
tion of mediators (such as PAI-1) that are profibrotic [25].
These recent studies add weight to the question answered
in these studies—is plasmin itself protective in renal in-
terstitial fibrosis?
Mice deficient in plasminogen are also deficient in plas-
min and plasmin activity and since their generation in
1995 have been used in several systems to test the role
of plasmin in normal and pathologic processes [2, 6, 26–
28]. Using a model of renal interstitial fibrosis induced by
UUO, our studies find that fibrosis is not accelerated in
the absence of plasmin, at two time points, 7 days and
21 days. Quantitative measurements of collagen accu-
mulation by hydroxyproline assay showed no increase
in renal collagen content at 1 week and a small but sta-
tistically significant decrease in renal collagen content in
plg−/− mice, that lack plasmin, at 3 weeks. There were no
significant differences in fibrosis in histologically stained
sections assessed by point counting, which may reflect
differences between assessing renal collagen content bio-
chemically and histologically by considering the presence
or absence of collagen in each individual point of a 10 ×
10 grid. Therefore, endogenous plasmin does not protect
from interstitial fibrosis, and in fact may have deleterious
effects.
Plasminogen-plasmin has the capacity to recruit
macrophages via the binding of plasminogen to annexin
II [29]. In our studies, UUO resulted in a dense intersti-
tial infiltrate of macrophages that could not be accurately
individually counted but could be semiquantitatively as-
sessed by examining the degree of infiltrate in a number
of high powered fields from each animal. While no dif-
ference could be detected at 1 week, at 3 weeks, the time
point at which there was more collagen accumulation,
obstructed kidneys from plg−/− mice had a less dense
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Fig. 4. Analysis of transforming growth factor-b1 (TGF-b1) and big-h3
mRNA in obstructed kidneys from plg+/+and plg−/− mice at 7 and 21
days. TGF-b1 and big-h3 mRNA are compared with the housekeeping
gene 18S, with the big-h3:TGF-b1 mRNA ratio providing an index of
active to total TGF-b . Results are expressed in arbitrary units (AU)
relative to plg+/+ mice at day 7. (A) There was a trend, but no significant
difference (P = 0.114) to increased TGF-b1 mRNA at day 7, that was
not continued at day 21. (B) There was no significant reduction in big-
h3 mRNA (P = 0.11 at 21 days). (C) There was a strong trend (P =
0.057 at either time point) to reduced big-h3:TGF-b1 mRNA ratios in
plg−/− mice.
macrophage infiltrate. This finding may help explain
the reduction in renal collagen accumulation in plg−/−
mice, as evidence is accumulating that macrophages
are pathogenetic in renal fibrosis [30]. Recent studies
Table 3. Matrix metalloproteinase (MMP)-9 in plg+/+ and plg−/−
mice with unilateral ureteral obstruction (UUO)
Pro-MMP-9 MMP-9
Day 7
Contralateral plg+/+ 51.2 ± 8.5 79.0 ± 31.0
plg−/− 54.7 ± 13.9 52.8 ± 12.4
Obstructed plg+/+ 98.7 ± 17.8 103.5 ± 23.0
plg−/− 54.0 ± 9.3 92.9 ± 17.6
Day 21
Contralateral plg+/+ 21.0 ± 1.4 41.9 ± 10.3
plg−/− 14.5 ± 1.8 39.3 ± 11.1
Obstructed plg+/+ 39.8 ± 11.3 50.0 ± 14.0
plg−/− 30.8 ± 1.7 40.1 ± 1.1
Levels of MMP-9 were unaltered in the absence of plasminogen. Results are
expressed in arbitrary units.
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Fig. 5. Gelatin zymography showing pro-matrix metalloproteinase
(MMP)-9 and active MMP-9, and pro-MMP-2 and active MMP-2 ac-
tivity in kidneys from plg+/+ and plg−/− mice. Pro-MMP-2 but not
active MMP-2 activity is measurable in contralateral kidneys and active
MMP-2 is increased in obstructed kidneys from plg+/+ mice, but to a
lesser degree in plg−/− mice. Plasmin is not required for MMP-9 acti-
vation. Representative samples from each group of mice were chosen.
suggest that macrophage depletion, while not affecting
interstitial fibroblast accumulation, did reduce collagen
deposition [abstract; Kipari, et al, J Am Soc Nephrol
13:541A, 2002]. In agreement with this report, our stud-
ies found that despite reduced macrophage accumu-
lation, plg−/− mice did not have decreased a-SMA–
positive interstitial myofibroblasts at either time point
studied. However, not all studies have demonstrated
that increased macrophage accumulation results in in-
creased collagen deposition. Recent studies in uPAR−/−
mice [25] and angiotensin II type 1 receptor–deficient
(Agtr−/−) mice suggest that both activation status and
potentially protective functions of macrophages are rel-
evant to fibrosis [31].
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Table 4. Matrix metalloproteinase (MMP)-2 in plg+/+ and plg−/−
mice with unilateral ureteral obstruction (UUO)
Pro-MMP-2 MMP-2
Day 7
Contralateral plg+/+ 44.2 ± 23.9 ND
plg−/− 25.5 ± 3.7 ND
Obstructed plg+/+ 58.8 ± 21.7 11.4 ± 0.9
plg−/− 76.6 ± 17.4 13.2 ± 1.3
Day 21
Contralateral plg+/+ 20.8 ± 3.9 ND
plg−/− 14.9 ± 1.2 ND
Obstructed plg+/+ 47.6 ± 3.3 46.2 ± 1.4
plg−/− 57.0 ± 9.4 25.1 ± 2.1a
ND is not detectable. Active MMP-2 was so low as to be undetectable in
contralateral kidneys but was present in obstructed kidneys and at day 21 was
lower in plg−/− mice than in plg+/+ mice. Results are expressed in arbitrary
units.
aP = 0.03 compared with plg+/+ mice (Mann-Whitney U test).
Endogenous plasmin plays an important role in lim-
iting crescentic glomerulonephritis [6], where glomeru-
lar fibrin has been shown to be an important mediator
of injury [32, 33]. The model used in the current studies
is not classically mediated by fibrin, although the defini-
tive functional study of UUO in fibrinogen-deficient mice
has yet to be performed. In previous studies in experi-
mental crescentic glomerulonephritis, fibrin was shown
to be chemotactic for macrophages [34], and glomeru-
lar macrophage accumulation was increased in plg−/−
mice [6] together with a major increase in glomerular
fibrin deposition. In contrast, the current studies found
fewer macrophages in the interstitium of plg−/− mice,
concordant with the findings of Ploplis et al [12], who
showed impaired migration of macrophages into the peri-
toneum of thioglycollate-treated plg−/− mice. Assess-
ment of macrophage numbers in glomeruli in our study
(although this model is not characterized by prominent
macrophage accumulation) showed low numbers (<0.2
per glomerular cross section) of F4/80+ cells and no
difference between plg+/+ and plg−/− mice (data not
shown). Differences in macrophage recruitment in the
two studies are likely to be due to both the relative con-
tributions of fibrin to the lesions, and to the potential for
macrophages in glomeruli to express a different pheno-
type to those in the interstitium [35].
TGF-b is a key fibrogenic growth factor that has been
convincingly implicated in both human and experimental
renal interstitial fibrosis [13–15]. It is secreted as a latent
form non-covalently associated with the TGF-b propep-
tide homodimer [16] and requires conversion to an active
form. Plasmin is capable of activating TGF-b [16] and in
the current studies we have provided evidence that in vivo
this occurs. Measuring mRNA for TGF-b1 and for big-
h3, a TGF-b responsive gene [23], mice plg−/− mice had
an approximately 50% reduction in big-h3 mRNA when
compared with TGF-b1 mRNA. These data suggest that
at least in this experimental model of renal fibrosis plas-
min is playing a role in converting TGF-b to its active
form and highlight a potentially pathogenetic effect of
plasmin in renal interstitial fibrosis.
MMPs, secreted as inactive pro-MMPs and later acti-
vated, have significant roles in matrix turnover and also
in basement membrane degradation. While theoretically
increased active MMPs might limit renal collagen and
other matrix accumulation, data from studies in both the
kidney [8] and in other organs have highlighted to po-
tential injurious roles of MMPs. In the same model used
in the current studies, MMP-9 (gelatinase B) was acti-
vated by tPA and MMP-9 degraded tubular basement
membrane and promoted tubular epithelial cell to my-
ofibroblast transformation [8]. In our studies there were
no changes in MMP-9 activity in the absence of plas-
minogen, confirming that the changes observed in the
study of Yang et al [8] were, as their data suggested, plas-
min independent. However, in the absence of plasmin,
MMP-2 activity was decreased at 21 days. It is not clear
whether this is a direct effect of the absence of plasmin,
for although one study has suggested that plasmin can
activate MMP-2 from human mesangial cells [36], others
suggest that murine MMP-2 is not activated by plasmin
[37]. It is likely, however, that the reduction in MMP-2
is related to the decrease in activated TGF-b (measured
by big-h3:TGF-b mRNA ratio) observed in these studies,
as TGF-b may induce MMP-2 [38]. However, alternative
explanations such as activation by a macrophage-derived
soluble factor are possible.
Sex hormones have the potential to modify the pro-
gression of renal disease [39] and also may influence
components of the plasminogen-plasmin system [40]. Our
studies used male mice for the 7-day time point and fe-
male mice for the 21-day time point and both time points
were analyzed separately. It is possible that the similar
macrophage and collagen accumulation in male plg+/+
and plg−/− mice at 7 days might reflect differences be-
tween the magnitude of plasmin’s effects in males and
females, although other explanations, such as the timing
of events at different stages of fibrosis, are possible.
Given the potential protective and pathogenetic effects
of plasmin, the net effects of plasmin may be protective
or harmful depending on the relative contributions of, for
example, macrophage accumulation, matrix degradation,
TGF-b activation, and MMPs. The effects of inhibiting or
enhancing plasmin require careful evaluation in fibrosis
mediated by different fibrotic stimuli to establish the role
of plasmin in different fibrotic diseases.
CONCLUSION
These studies show that endogenous plasmin is not pro-
tective in experimental renal fibrosis, induced by ureteric
obstruction. They add significantly to our understanding
of the plasminogen-plasmin system in disease by demon-
strating that mechanism of fibrosis are organ-specific and
that plasmin can have deleterious effects in fibrotic injury.
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They demonstrate that pathogenetic effects observed in
renal fibrosis using mice deficient in other components
of the plasminogen-plasmin system (e.g., tPA and PAI-1)
are plasmin independent.
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